I. Caldwell

发表

Analysis of molecular cytogenetic changes in metastatic renal cell carcinoma in the setting of everolimus treatment: a pilot project.

P. Fong, R. Broom, P. Oei, 2014, Clinical genitourinary cancer.

Response to everolimus in a patient with refractory HGBL-NOS harboring multiple genomic aberrations in PTEN

S. Lade, C. Scott, T. Akhurst, 2021, Leukemia & lymphoma.

Time-Limited Ibrutinib and Tisagenlecleucel Is Highly Effective in the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma, Including Those with TP53 Mutated and Btki-Refractory Disease: First Report of the Tarmac Study

S. Lade, C. Tam, C. Cheah, 2022, Blood.

How long do acute coronary syndrome patients wait for reperfusion, diagnostic coronary angiography and surgical revascularisation?

A. Kerr, M. Lee, J. Voss, 2013, The New Zealand medical journal.

I. Caldwell, R. Doocey, B. Buckley, 2017, Internal medicine journal.